Skip to content
Economy · World
GENESIS Pharma Expands Partnership with Alnylam Pharmaceuticals in Scandinavia
2 sourcesFirst reported 1 month agoUpdated 1 month ago
Left 50%
Center 50%
1 left-leaning1 center
Left-leaning outlets dominate coverage at 50%. This often signals the story aligns with progressive priorities, or that right-leaning media is downplaying it. The 0% right-leaning coverage may offer a contrasting angle worth reading.
What all sources covered
- GENESIS Pharma is expanding its commercial collaboration with Alnylam Pharmaceuticals.
- The partnership now includes Denmark, Finland, Norway, and Sweden.
- This expansion complements GENESIS Pharma's existing presence in thirteen Southeast European markets.
- The focus of the collaboration is on RNAi therapies.
2 sources
Who reported first
in.grFirst
CNN Greece+24h
All coverage
